Patient participation in treatment decisions can have positive effects on patient satisfaction, compliance and health outcomes. The objectives of this study were to examine attitudes of psoriasis patients regarding participation in treatment decisions and to evaluate the effect of a decision-aid for discussing treatment options. A "quasi experiment" was conducted in a large dermatological hospital in Italy: a questionnaire evaluating the decision-making process and treatment knowledge was self-completed by 231 consecutive psoriasis patients after routine clinical practice and by a second sample of 171 patients exposed to a decision-board. In routine clinical practice 67.9% of patients wanted to be involved in decision-making, 28.4% wanted t...
Objective: To assess patient preferences for psoriasis treatment features and to investigate the het...
Background: Psoriasis is a common chronic inflammatory disease. Having more information about psoria...
Background: New technologies have enabled the potential for stratified medicine in psoriasis. It is ...
Background: Informed shared decision making is a mutual process engaging both doctor and patient and...
Introduction:Treatment adherence continues to be a major challenge in psoriasis. Patient preference ...
Introduction:Treatment adherence continues to be a major challenge in psoriasis. Patient preference ...
BACKGROUND:Each individual psoriasis patient has different expectations and goals for biological tre...
Background: In shared decision making (SDM), patients and physicians work together to choose the bes...
Treatment dissatisfaction and non-adherence are common among patients with psoriasis, partly due to ...
Shared decision making combines individual patient interests and values with clinical best evidence ...
A nationwide survey was conducted in adult patients with psoriasis (PsO) across Italy to obtain thei...
BACKGROUND: Clinical decisions over psoriasis are based on many factors. Patients' quality of life (...
Lina Eliasson,1 Anthony P Bewley,2 Farhan Mughal,3 Karissa M Johnston,4 Andreas Kuznik,5 Chloe Patel...
Systemic antipsoriatic treatment options are increasing rapidly. The aim of this nationwide discrete...
Shared decision making combines individual patient interests and values with clinical best evidence ...
Objective: To assess patient preferences for psoriasis treatment features and to investigate the het...
Background: Psoriasis is a common chronic inflammatory disease. Having more information about psoria...
Background: New technologies have enabled the potential for stratified medicine in psoriasis. It is ...
Background: Informed shared decision making is a mutual process engaging both doctor and patient and...
Introduction:Treatment adherence continues to be a major challenge in psoriasis. Patient preference ...
Introduction:Treatment adherence continues to be a major challenge in psoriasis. Patient preference ...
BACKGROUND:Each individual psoriasis patient has different expectations and goals for biological tre...
Background: In shared decision making (SDM), patients and physicians work together to choose the bes...
Treatment dissatisfaction and non-adherence are common among patients with psoriasis, partly due to ...
Shared decision making combines individual patient interests and values with clinical best evidence ...
A nationwide survey was conducted in adult patients with psoriasis (PsO) across Italy to obtain thei...
BACKGROUND: Clinical decisions over psoriasis are based on many factors. Patients' quality of life (...
Lina Eliasson,1 Anthony P Bewley,2 Farhan Mughal,3 Karissa M Johnston,4 Andreas Kuznik,5 Chloe Patel...
Systemic antipsoriatic treatment options are increasing rapidly. The aim of this nationwide discrete...
Shared decision making combines individual patient interests and values with clinical best evidence ...
Objective: To assess patient preferences for psoriasis treatment features and to investigate the het...
Background: Psoriasis is a common chronic inflammatory disease. Having more information about psoria...
Background: New technologies have enabled the potential for stratified medicine in psoriasis. It is ...